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Abstract. Treatment failures to the first- and second-lines antimalarial drugs chloroquine and sulfadoxine-
pyrimethamine have increased in the Purworejo district on the island of Java, Indonesia. A molecular epidemiologic
study was conducted to determine the frequency distribution of mutant alleles of the genes associated with the resistance
among the isolates of Plasmodium falciparum from the area. Analyses using a polymerase chain reaction and restriction
fragment length polymorphism showed that nearly all of the 111 samples carried mutant alleles in genes associated with
chloroquine resistance: P. falciparum multi-drug resistance 1 (pfmdr1) 86Y (92%), 1042D (4.5%), and P. falciparum
chloroquine resistance transporter (pfcrt) 76T (99.1%). Mutant alleles of the in the dihydrofolate reductase (dhfr) gene
were also high (84.7%), either as 108N and 108T or paired with 59R, and 16V, respectively. Mutant alleles in the
dihydropteroate synthase gene were the least common, either as a single 437G mutation (35.3%) or paired with 540E
(26.5%). These results are consistent with the antimalarial drug resistance situation in the area and emphasize the need
for a proper treatment strategy.
INTRODUCTION
Malaria incidence on much of the Indonesian islands of
Java and Bali, Indonesia had been successfully eliminated or
reduced to hypoendemic status by the Government-initiated
malaria control program in 1952, although in some foci per-
sistent transmission still occurs.1 The prolonged political and
socioeconomic crisis within the last few years, however, has
changed the malaria situation in many parts of Indonesia,
including Java. Several outbreaks have been documented in
areas previously declared malaria free. Malaria incidence has
increased in the Menoreh Hills, a malaria-endemic focus in
central Java that includes the Magelang, Purworejo, and Ku-
lon Progo districts, as shown by the persistent increase of
annual parasite incidence since 1995 (Ministry of Health, un-
published data).
Surveys conducted within the last few years indicated that
chloroquine resistance has spread almost homogeneously in
the entire archipelago.2–8 Resistance of Plasmodium falci-
parum to chloroquine, quinine, and mefloquine had been also
documented in Purworejo district by either in vivo or in vitro
drug resistance tests. In the subdistricts of Kemiri, Loano, and
Bener, the prevalence of resistance to chloroquine was 73%
R-I level, 22.4% R-II, and 4.5% R-III in 1995,9 while in the
Pituruh subdistrict, chloroquine resistance was reported as
R-I (52%), R-II (3.6%) and R-III (0.4%) (Ministry of Health,
unpublished data). In vitro analyses conducted between 1981
and 1985 and 1986 and 1990 reported sulfadoxine-
pyrimethamine resistance in 71% and 22% of cases, respec-
tively, whereas the in vivo test found 12% resistance.9
As in other part of Indonesia, slide proven and/or clinically
diagnosed malaria is usually treated with a standard curative
regimen of chloroquine (25 mg base/kg of body weight in
three doses over a 72-hour period), followed by 15 mg of
primaquine base per day for two weeks for P. vivax or a single
dose of 45 mg of primaquine base for P. falciparum. In cases
of treatment failure, a standard formulation of sulfadoxine
and pyrimethamine (supplied by the Ministry of Health) is
given in accordance with the Ministry of Health guidelines.
Physicians or clinic staff generally give therapy to patients
mostly without supervision after the first dose.
Although treatment failure to the mainline antimalarial
drugs is currently increasing, the use of other alternative
drugs has not yet been recommended due to economic rea-
sons. During the latest malaria epidemic in Purworejo in Oc-
tober 2000, it was recommended to intensify the control pro-
gram through rational deployment of the available drugs.
Studies on the molecular basis of antimalarial drug resis-
tance over the last few decades revealed various mutant al-
leles of the P. falciparum chlorquine resistance transporter
(pfcrt) and the P. falciparum multi-drug resistance 1 (pfmdr
1) genes that were associated with resistance to chloro-
quine.10 Similarly, mutant alleles of the dhfr and dhps genes
had also been implicated in the Plasmodium spp. resistance to
antifolates and sulfa drugs, respectively.11 Many epidemio-
logic studies have been conducted on the frequency distribu-
tion of the alleles among the P. falciparum isolates from dif-
ferent geographic regions. These studies have proven to be an
invaluable tool in evaluating the spread of drug resistance in
many countries.12–22
The aim of the present study was to determine the fre-
quency distribution of the mutant alleles of genes associated
with resistance to chloroquine and sulfadoxine-pyrimetha-
mine among the P. falciparum isolates from Purworejo dis-
trict, Central Java Province, Indonesia.
MATERIALS AND METHODS
Study site. The location of the Purworejo district within the
Central Java Province of Indonesia is shown in Figure 1. The
Purworejo district is located along the western slope of Meno-
reh Hill and shares a border with the Kulon Progo District of
the Yogjakarta special Province. Purworejo district has an
area of 1,034 km2 and is divided into 16 subdistricts, and
includes rugged terrain, valleys used for rice fields and teak or
bamboo forest-covered hillsides. Most of the cultivated lands
are used for rice fields, but coconut, salak, papaya, jackfruit,
and pineapple are also cultivated. The majority of the 733,840
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residents work as farmers. The survey was conducted in
Sokoagung village in the Bagelen subdistrict. This village has
a population of approximately 2,200 people and has been one
of the malaria foci in the Purworejo district with mesoen-
demic status for infection by P. vivax and P. falciparum. The
climate is typically tropical with a monsoon occurring be-
tween November and March. The village is characterized by
rough terrain and was subject to heavy rains leading to land-
slides and floods during the surveys.
Sample collection. A malariometric survey was conducted
during October and November 2000, and 182 blood samples
from malaria-infected individuals were collected as blots on
filter paper (3MM; Whatman, Hillsboro, OR). Plasmodium
falciparum−infected samples, as revealed by microscopic ex-
amination of a blood smear, were used for DNA isolation.
This study was carried out with the approval by the Ethics
Committees for Protection of Human Subjects at the Eijkman
Institute for Molecular Biology (Jakarta, Indonesia).
Extraction of DNA. Parasite DNA was extracted from the
blood samples using Chelex-100 (Bio-Rad Laboratories, Her-
cules, CA) ion exchanger, essentially according to the proce-
dure previously described.23 The DNA was used immediately
for a polymerase chain reaction (PCR) or stored at -20°C for
subsequent use.
Amplification by PCR and detection of mutant alleles. A
PCR) and restriction fragment length polymorphism (RFLP)
were performed for four genes (dihydrofolate reductase
[dhfr], dihydropteroate synthase [dhps], pfmdr1, and pfcrt) to
identify the presence of mutant alleles. All reactions were
carried out as described previously for dhfr, dhps, and
pfmdr1.20,21,24,25
RESULTS
A total of 182 blood samples from P. falciparum-infected
individuals were examined for the presence of mutations in
the pfcrt, pfmdr1, dhfr, and dhps genes. Our results show that
among the blood samples examined, only 111 gave PCR re-
sults. There were 35 samples (31.5%) that indicate mixed
infections of both wild-type and mutant alleles, as shown by
the pattern of RFLP in at least one of the gene PCR products
(Table 1).
Mutant alleles of the pfmdr1 and pfcrt genes. Analysis of
pfmdr1 gene PCR products indicated that mutant alleles of
this gene have spread to all samples examined in Purworejo
District (Table 1). The most common allele of the pfmdr1
gene among the field isolates of P. falciparum was 86Y. The
1042 allele was also observed at a lower frequency (4.5%),
FIGURE 1. Map of the Central Java Province of Indonesia showing the location of Sokoagung village, the Bagelen Sub-district, the Purworejo
District (gray area), the Menoreh Hill area (triangle), and Sokoagung village (oval). The inset shows the entire Indonesian archipelago.
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and was paired with allele 86Y, except in one isolate. Mutant
allele 76T in the pfcrt gene was found in most samples
(99.1%), but it was mixed with wild-type allele 76K in one
case. Except in four samples, all P. falciparum isolates carried
mutant allele 76T of the pfcrt gene paired with the either 86Y
or 1042D alleles of the pfmdr1 gene. Alleles 1034C and 1246Y
were not found in any of the samples examined.
Mutant alleles of the dhfr and dhps genes. Mutant alleles in
the dhfr gene were found in 94 samples (84.7%) either as a
single 108N or 108T, or else paired with alleles 16V and 59R
(Figure 2). In four samples, the 59R mutation was found as a
single mutation. There were 42 isolates (30.2%) that carry
alleles 108N and 59R simultaneously. The 108T allele was
detected in 34 isolates (27.4%), and among these, 32 were
paired with 16V. Mutant alleles at codons 50, 51, and 164 were
not observed in any of the samples examined in Indonesia.
Mutant alleles of the dhps gene were the least common
among the four genes examined in this study (Figure 2). The
most common allele was 437G (35.3%), and was found either
as single mutation or paired with the 540E allele (26.5%).
Mutant alleles at codons 436, 581, and 613 were not observed
in any of the samples examined in this study. With the excep-
TABLE 1
Genotypic profiles of Plasmodium falciparum isolates from Purworejo District, Indonesia*
Sample
no.
DHFR DHPS Pfmdr 1 Pfcrt
Number
of isolates16V 59R 108N/T 437G 540E 86Y 1042D 76T
1 A C S A K Y N T 13
2 A R N A K Y N T 13
3 A C N A K Y N T 10
4 V C T A K Y N T 6
5 A C N G E Y N T 5
6 V R T A K Y N T 4
7 A R N G E Y N T 4
8 V R N/T A K Y N T 4
9 A R S/N A K Y N T 3
10 A C N G K Y N T 3
11 A R S A K Y N T 2
12 V C T G K Y N T 2
13 V C/R T A K Y N T 2
14 A C S G E Y N T 2
15 V R T G E Y N T 1
16 A C S A K N N K/T 1
17 A C S A K N N T 1
18 A R N G E Y D T 1
19 A R N G K Y N T 1
20 A R N G E N N T 1
21 A R N G K N N T 1
22 V C S G K Y N T 1
23 V C T G E Y N T 1
24 A C T A K Y N T 1
25 V C T G E N N T 1
26 A R S G K Y N T 1
27 A R S G E Y N T 1
28 A C/R N/T G K Y N T 1
29 A R N G K/E Y N T 1
30 A/V C N/T G E Y N T 1
31 A/V C N/T G E Y D T 1
32 A C/R N A K Y N T 1
33 A C/R N G E N D T 1
34 V R N/T G K Y N T 1
35 V C T A/G K/E Y N T 1
36 V C/R T A/G E Y N T 1
37 V C/R N/T A K Y N T 1
38 A C S/N A/G E Y D T 1
39 V C/R S A K Y N T 1
40 A/V R N/T A K Y N T 1
41 A R N A/G K/E Y D T 1
42 A/V C T A K Y N T 1
43 A R N G E N/Y N T 1
44 A R N A K/E Y N T 1
45 A R S/N A K/E Y N T 1
46 A R S/N G E Y N T 1
47 A R S/N A K Y N T 1
48 A R S/N G K Y N T 1
49 V C N/T A K Y N T 1
50 V R N/T G E Y N T 1
51 A/V C N/T A K Y N T 1
52 A C S/N A K N/Y N T 1
* DHFR dihydrofolate reductase; DHPS dihydropteroate synthase; Pfmdr 1 P. falciparum multi-drug resistance 1 gene; Pfcrt P. falciparum chloroquine resistance transporter gene.
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tion of two samples, mutations in the dhps gene was also
paired with one or more mutations in dhfr gene.
DISCUSSION
Our results showed that all of the field isolates of P. falci-
parum from the Purworejo district carried a mutant allele of
at least one the genes that are associated with resistance to
the front-line antimalarial drugs chloroquine and sulfadoxine-
pyrimethamine. There were also high proportions of P. falci-
parum isolates that carry more than one mutant allele in all
genes analyzed.
Mutant alleles associated with chloroquine resistance, 76T
of the pfcrt gene paired with either 86Y or 1042D of the
pfmdr1 gene, predominated the genotypic patterns of P. fal-
ciparum isolates in the Purworejo District. This may reflect
the increasing cases of treatment failure with the standard
dose of chloroquine within the last few years in the area. The
antimalarial drug resistance situation in Purworejo has not
been extensively studied until recently. In vivo and in vitro
drug sensitivity tests performed between 1981 and 1995 re-
ported resistance to chloroquine in 24−60% of the cases and
resistance to sulfadoxine-pyrimethamine in 12−70% of the
cases. However, this result has not altered the antimalarial
drug policy in the area because only a small number of
samples were examined.9 Our recent in vitro tests found three
P. falciparum isolates collected from the nearby Pituruh sub-
district that were highly resistant to chloroquine with similar
genotypic patterns to the PCR samples. These data, if taken
together, indicate that the current standard chloroquine treat-
ment dose may no longer effectively eliminate the malaria
infection.8,26
The molecular basis for the malaria parasite resistance to
quinoline antimalarials has long been a central issue in ma-
laria research because chloroquine is the most widely used
antimalarial drug. Evidence to date indicates that the resis-
tance may involve more than one gene. Various sets of poly-
morphism in pfcrt gene have been associated with chloro-
quine resistance. Mutant allele 76T of the pfcrt gene has been
shown to play a determining role in chloroquine resistance,
although it was also present to a lesser frequency in a chlo-
roquine-sensitive strain.21,22 This evidence suggests that the
existence of other mutant alleles is required, or that several
genes may be involved in chloroquine resistance. Our findings
that most P. falciparum isolates in the area carry both mutant
alleles in the pfcrt and pfmdr1 genes simultaneously gives
support for this idea. Linkage disequilibrium between pfcrt
76T and pfmdr1 86Y was noted in Africa.27,28 The 1042D
allele of the pfmdr1 gene was also observed in few isolates of
P. falciparum in Purworejo. This allele was mainly found in
the eastern part of Indonesia, and was exclusively predomi-
FIGURE 2. Histogram of the frequency distribution of mutant alleles of Plasmodium falciparum associated with resistance to sulfadoxine-
pyrimethamine. Mutant alleles 50R, 51I, and 164L of the dihydrofolate reductase (dhfr) gene were not found in any of the samples examined.
Mutant alleles 436F/A, 581G, and 613S/T of the dihyropteroate synthase (dhps) gene were not observed in any of the isolates examined.
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nant in isolates from Flores. It is of interest to note the pres-
ence of isolates carrying both 86Y and 1042D alleles of the
pfmdr1 gene. At this stage, it is unclear whether multiple
mutations in this gene confer a higher degree of resistance to
chloroquine and its derivatives. Allelic exchange experiments
indicated that 1034C, 1042D, and 1246Y alleles of the pfmdr1
gene reduced the chloroquine 50% inhibitory concentration
(IC50).
29
Given the rapid spread of chloroquine resistance to many
parts of Indonesia over the last two decades, it is not surpris-
ing to find that the P. falciparum isolates in Indonesia have
indeed carried mutant alleles in genes that are associated with
resistance to this drug.
Of the 111 P. falciparum isolates examined in this study, we
found that only 19 carried wild-type allele of the dhfr gene.
The remainder carried alleles 108N or 108T, either as a single
mutation or in combination with the 59R and 16V mutations.
Additionally, we also found the double mutant alleles
108N+59R in 42 isolates and 108T+16V in 32 isolates. These
findings indicate that these isolates were resistant to anti-
folate antimalarial drugs. Two antifolate drugs are currently
used, pyrimethamine and proguanil (cycloguanil). Pyrimeth-
amine has always been used in combination with sulfadoxine,
whereas proguanil is available as a single drug, paludrine, and
more recently also in combination with atovaquone (Ma-
larone®; GlaxoSmithKline, Middlesex, United Kingdom),
The molecular mechanism that underlies resistance to anti-
folate antimalaria drugs involves the S108N/T mutation in the
dhfr gene. Resistance to pyrimethamine is mainly linked to
the 108N mutation, whereas cycloguanil resistance is exclu-
sively linked to the 16V and 108T mutations. The 108N mu-
tation alone would confer an approximately 100-fold increase
in resistance to pyrimethamine compared with the wild-type
allele 108S.30,31 The presence of other mutations (51I, 59R,
and 164L) not only enhances resistance but also confers cross-
resistance to both antifolate drugs.32–34
The results are also of particular interest in terms of resis-
tance to cycloguanil. There were 32 P. falciparum isolates that
genotypically indicate an exclusive resistance to this drug, the
active form of proguanil, although this drug has never been
officially used in Indonesia. There are several explanations
that may explain this result. First, proguanil-containing anti-
malarial drugs may have been used in the area or the parasite
isolates may have been imported from an area where the drug
has been used. Second, there may be other drugs with action
similar to cycloguanil, such as trimethoprim, a weak inhibitor
of dihydrofolate reductase, which are commonly used in com-
bination with sulfamethoxazole for treatment of bacterial dis-
eases.35
In this study, mutant alleles of the dhps gene were found
less frequently in P. falciparum isolates compared with the
other genes analyzed. However, this prevalence was much
higher than the 3% previously observed in the adjacent sub-
district of Kokap in 1999. This indicates that the wider use of
the second-line antimalarial sulfadoxine-pyrimethamine
within the last few years in the area has significantly increased
the prevalence of P. falciparum isolates carrying the resistant
genotypes. The role of dhps mutations in the mechanism of
resistance to sulfa drugs has been well described. The 437G
mutation confers resistance to sulfadoxine in P. falciparum,
and when coupled with the additional mutant allele 540E, the
level of resistance is increased.36 The finding that almost 25%
of the P. falciparum isolates from Purworejo carry double
mutations in the dhps gene emphasizes the need for careful
prescription of sulfadoxine-pyrimethamine because it may be
the last affordable antimalarial drug in this area.
The combination of pyrimethamine-sulfadoxine, also
known as Fansidar® (F. Hoffmann-LaRoche, Basel, Switzer-
land), has been used mainly as a second-line antimalarial drug
in Indonesia. Resistance to this drug has also consistently
spread to many malaria-endemic areas in this country. It is
not clear whether mutations in both the dhfr and dhps are
required to confer resistance to Fansidar. Previous studies in
Africa indicated that resistance to sulfadoxine-pyrimeth-
amine in vivo was associated with the presence of triple mu-
tant alleles 108N, 51I, and 59R in the dhfr gene with or with-
out the mutant alleles 437G and 540E in the dhps gene.15–18
Although this study did not find any isolates that had quin-
tuple mutations in the dhfr and dhps genes, it may be of
particular importance to note that the current practice of un-
supervised use of Fansidar will certainly facilitate the devel-
opment of parasite resistance to this drug. Our previous in
vivo test in western Papua New Guinea indicated that muta-
tions in both the dhfr and dhps genes are required for resis-
tance to Fansidar.20
In conclusion, molecular analyses of antimalarial drug re-
sistant alleles of P. falcifarum isolates in the Purworejo dis-
trict strongly indicate the widespread distribution of chloro-
quine-resistance, and to a lesser extent, sulfadoxine-
pyrimethamine−resistant isolates in this area. These results
emphasize the need for proper use of antimalarial drugs in
this area and in Indonesia in general because most other al-
ternative antimalarial drugs are currently unaffordable. With
the current increase in malaria morbidity and mortality in
Indonesia, a national malaria control strategy that permits
malaria treatment without a prior laboratory diagnosis should
be revisited.
Received March 26, 2003. Accepted for publication September 13,
2003.
Acknowledgments: We thank officials of the Ministry of Health in
Purworejo District and at the selected subdistrict and villages for
providing us with technical support during the malariometric surveys,
Dr. F. Laihad (Malaria Section, Center for Communicable Diseases
Control, The Ministry of Health) and Dr. M. Duffy (Australia-
Indonesia Medical Research Initiative) for critically reading the
manuscript. We also thank Professor Sangkot Marzuki (Director of
the Eijkman Institute, Jakarta) for his invaluable support and input.
Financial support: This work was supported in part by The Indone-
sian Government through Bappenas, the Australia-Indonesia Medi-
cal Research Initiative project, a fellowship from the American So-
ciety of Tropical Medicine and Hygiene awarded to Sona L. Aggar-
wal, and by a Prebluda Fellowship grant awarded to Anuraj H.
Shankar.
This work also received support from the Nutrition and Health Sur-
veillance System Cooperative Agreement No. 497-a-00-99-00033-00
between USAID-Indosia and Helen Keller International.
Authors’ addresses: D. Syafruddin, Eijkman Institute for Molecular
Biology, Jl. Diponegoro 69, Jakarta 10430, Indonesia and Depart-
ment of Parasitology, Faculty of Medicine, Hasanuddin University, Jl.
Perintis Kemerdekaan Km 10, Makassar 90245, Indonesia. Puji B. S.
Asih, Eijkman Institute for Molecular Biology, Jl. Diponegoro 69,
Jakarta 10430, Indonesia. Sona L. Aggarwal, Johns Hopkins School
of Medicine, Baltimore, MD 21205. Anuraj H. Shankar, Helen Keller
International, Jl. Bungur Dalam 23 A, Kemang, Jakarta 12730, Indo-
nesia.
SYAFRUDDIN AND OTHERS618
Reprint requests: D. Syafruddin, Eijkman Institute for Molecular Bi-
ology, Jalan Diponegoro 69, Jakarta 10430, Indonesia, Telephone:
62-21-3917131, Fax: 62-21-3147982, E-mail: din@eijkman.go.id
REFERENCES
1. Baird JK, Sismadi P, Masbar S, Ramzan A, Purnomo BW, Sekar-
tuti, Tjitra BW, Rumoko BW, Arbani PR, 1995. A focus of
hyperendemic malaria in Central Java. Am J Trop Med Hyg
54: 98−104.
2. Ebisawa I, Fukuyama T, 1975. Chloroquine-resistant falciparum
malaria from West Irian and East Kalimantan. Ann Trop Med
Parasitol 69: 131–132.
3. Ebisawa I, Fukuyama T, 1975. Chloroquine resistance of Plas-
modium falciparum in West Irian and East Kalimantan. Ann
Trop Med Parasitol 69: 275–282.
4. Clyde DF, McCarthy VC, Miller RM, Hornick RB, 1976. Chlo-
roquine-resistant falciparum malaria from Irian Jaya (Indone-
sian New Guinea). J Trop Med Hyg 79: 38–41.
5. Fryauff DJ, Sumawinata I, Purnomo, Richie TL, Tjitra E, Bangs
MJ, Kadir A, Ingkokusumo G, 1999. In vivo responses to an-
timalarials by Plasmodium falciparum and Plasmodium vivax
from isolated Gag Island of northwest Irian Jaya, Indonesia.
Am J Trop Med Hyg 60: 542−546.
6. Smrkovski LL, Hoffman SL, Purnomo, Hussein RP, Masbar S,
Kurniawan L, 1983. Chloroquine resistant Plasmodium falci-
parum on the Island of Flores, Indonesia. Trans R Soc Trop
Med Hyg 77: 459−462.
7. Verdrager J, Arwati S, 1974. Resistant Plasmodium falciparum
infection from Samarinda. Kalimantan. Buletin Penelitian
Kesehatan 2: 43–50.
8. Baird JK, Wiady I, Fryauff DJ, Sutanihardja MA, Leksana B,
Widjaya H, Kysdarmanto, Subianto B, 1997. In vivo resistance
to chloroquine by Plasmodium vivax and Plasmodium falci-
parum at Nabire, Irian Jaya, Indonesia. Am J Trop Med Hyg
56: 627−631.
9. Tjitra E, Gunawan S, Laihad F, Marwoto H, Sulaksono S, Arjoso
S, Richie TL, Manurung N, 1997. Evaluation of antimalarial
drugs in Indonesia 1981-1995. Buletin Penelitian Kesehatan 25:
27–58.
10. Wellems TE, Plowe CV, 2001. Chloroquine-resistant malaria. J
Infect Dis 184: 770–776.
11. Cowman AF, 1998. The molecular basis of resistance to the sul-
fone, sulfonamides, and dihydrofolate reductase inhibitors.
Sherman IW, ed. Malaria Parasite Biology, Pathogenesis and
Protection. Washington, DC: American Society for Microbiol-
ogy Press, 317−330.
12. Basco LK, Ringwald P, 1997. pfmdr1 gene mutation and clinical
response to chloroquine in Yaounde, Cameroon. Trans R Soc
Trop Med Hyg 91: 210–211.
13. Curtis J, Duraisingh MT, Warhurst DC, 1998. In vivo selec-
tion for a specific genotype of dihydropteroate synthase of
Plasmodium falciparum by pyrimethamine-sulfadoxine but
not chlorproguanil-dapsone treatment. J Infect Dis 177: 1429–
1433.
14. Gomez-Saladin E, Fryauff DJ, Taylor WR, Laksana BS, Susanti
AI, Purnomo, Subianto B, Richie TL, 1999. Plasmodium fal-
ciparum mdr1 mutations and in vivo chloroquine resistance in
Indonesia. Am J Trop Med Hyg 61: 240−244.
15. Jelinek T, Kilian AH, Kabagambe G, von Sonnenburg F, 1999.
Plasmodium falciparum resistance to sulfadoxine/pyrimeth-
amine in Uganda: correlation with polymorphisms in the dihy-
drofolate reductase and dihydropteroate synthetase genes. Am
J Trop Med Hyg 61: 463–466.
16. Basco LK, Tahar R, Ringwald P, 1998. Molecular basis of in vivo
resistance to sulfadoxine-pyrimethamine in African adult pa-
tients infected with Plasmodium falciparum malaria parasites.
Antimicrob Agents Chemother 42: 1811–1814.
17. Nzila AM, Mberu EK, Sulo J, Dayo H, Winstanley PA, Sibley
CH, Watkins WM, 2000. Towards an understanding of the
mechanism of pyrimethamine-sulfadoxine resistance in Plas-
modium falciparum: genotyping of dihydrofolate reductase
and dihydropteroate synthase of Kenyan parasites. Antimicrob
Agents Chemother 44: 991–996.
18. Bwijo B, Kaneko A, Takechi M, Zungu IL, Moriyama Y, Lum
JK, Tsukahara T, Mita T, Takahashi N, Bergqvist Y, Bjorkman
A, Kobayakawa T, 2003. High prevalence of quintuple mutant
dhps/dhfr genes in Plasmodium falciparum infections seven
years after introduction of sulfadoxine and pyrimethamine as
first line treatment in Malawi. Acta Trop 85: 363–373.
19. Wang P, Read M, Sims PF, Hyde JE, 1997. Sulfadoxine resistance
in the human malaria parasite Plasmodium falciparum is de-
termined by mutations in dihydropteroate synthetase and an
additional factor associated with folate utilization. Mol Micro-
biol 23: 979–986.
20. Nagesha HS, Syafruddin D, Casey GJ, Susanti AI, Fryhauff DJ,
Reeder JC, Cowman AF, 2001. Mutations in the pfmdr1, dhfr
and dhps genes of Plasmodium falciparum are associated with
in vivo drug resistance in Irian Jaya, Indonesia. Trans R Soc
Trop Med Hyg 95: 43–49.
21. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov, Fer-
dig MT, Ursas LMB, Sidhu AS, Naude B, Deltsch KW, Su XZ,
Wootton JC, Roepe PD, Wellems TE, 2000. Mutations in the
P. falciparum digestive vacuole transmembrane protein pfCRT
and evidence for their role in chloroquine resistance. Mol Cell
5: 861−871.
22. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Dioutte Y,
Doumbo S, Dicko A, Su XZ, Nomura T, Fidock DA Wellems
T, Plowe CV, Coulibaly D, 2001. A molecular marker for chlo-
roquine-resistant falciparum malaria. N Engl J Med 344:
257−263.
23. Wooden J, Kyes S, Sibley CH, 1993. PCR and strain identification
in Plasmodium falciparum. Parasitol Today 9: 303–305.
24. Duraisingh MT, Drakeley CJ, Muller O, Bailey R, Snounou G,
Targett GA, Greenwood BM, Warhurst DC, 1997. Evidence
for selection for the tyrosine-86 allele of the pfmdr 1 gene of
Plasmodium falciparum by chloroquine and amodiaquine.
Parasitology 114: 205–211.
25. Duraisingh MT, Curtis J, Warhurst DC, 1998. Plasmodium falci-
parum: detection of polymorphisms in the dihydrofolate re-
ductase and dihydropteroate synthetase genes by PCR and
restriction digestion. Exp Parasitol 89: 1–8.
26. Fryauff DJ, Baird JK, Candradikusuma D, Masbar S, Sutami-
harja MA, Leksana B, Sekartuti, Marwoto H, Richie T, Rom-
zan A, 1997. Survey of in vivo sensitivity to chloroquine by
Plasmodium falciparum and P. vivax in Lombok, Indonesia.
Am J Trop Med Hyg 56: 241−244.
27. Babiker HA, Pringle SJ, Abdel-Muchsin A, Mackinnon M, Hunt
P, Walliker D, 2001. High- level chloroquine resistance in
Sudanese isolates of P. falciparum is associated with mutations
in the chloroquine resistance transporter gene, pfcrt and the
multidrug resistance gene pfmdr1. J Infect Dis 183: 1535–1538.
28. Adagu IS, Warhurst DC, 2001. Plasmodium falciparum linkage
disequilibrium between loci in chromosome 7 and 5 and chlo-
roquine selective pressure in Northern Nigeria. Parasitology
123: 219–224.
29. Reed MB, Saliba KS, Caruana SR, Kirk K, Cowman AF, 2000.
Pgh1 modulates sensitivity and resistance to multiple antima-
larials in Plasmodium falciparum. Nature 403: 906–909.
30. Peterson DS, Walliker D, Wellems TE, 1988. Evidence that a
point mutation in dihydrofolate reductase-thymidylate syn-
thase confers resistance to pyrimethamine in falciparum ma-
laria. Proc Natl Acad Sci USA 85: 9114–9118.
31. Cowman AF, Morry MJ, Biggs BA, Cross GAM, Foote SJ, 1988.
Amino acid changes linked to pyrimethamine resistance in the
dihydrofolate reductase-thymidylate synthase gene of Plasmo-
dium falciparum. Proc Natl Acad Sci USA 85: 9109–9113.
32. Foote Sj, Galatis D, Cowman AF, 1990. Amino acids in the di-
hydrofolate reductase-thymidilate synthase gene of Plasmo-
dium falciparum involved in the cycloguanil resistance differ
from those involved in pyrimethamine resistance. Proc Natl
Acad Sci USA 87: 3014−3017.
ANTIMALARIAL DRUG-RESISTANT ALLELES IN PURWOREJO, INDONESIA 619
33. Peterson DS, Milhous WK, Wellems TE, 1990. Molecular basis of
differential resistance to cycloguanil and pyrimethamine in
Plasmodium falciparum malaria. Proc Natl Acad Sci USA 87:
3018–3022.
34. Sirawaraporn W, Sachikul T, Sirawaraporn R, Yuthavong Y,
Santi DV, 1997. Antifolate resistant mutants of Plasmodium
falciparum dihydrofolate reductase. Proc Natl Acad Sci USA
94: 1124–1129.
35. Sibley CH, Hyde JE, Sims PFG, Plowe CV, Kublin JG, Mberu
EK, Cowman AF, Winstanley PA, Watkins WM, Nzila AM,
2001. Pyrimethamine-sulfadoxine resistance in Plasmodium
falciparum: what next? Trends Parasitol 12: 582–588.
36. Triglia T, Menting JGT, Wilson C, Cowman AF, 1997. Mutations
of dihydropteroate synthase are responsible for sulfone and
sulfonamide resistance in Plasmodium falciparum. Proc Natl
Acad Sci USA 94: 13944–13949.
SYAFRUDDIN AND OTHERS620
